5 completed, 1 terminated, 1 unknown, 1 withdrawn. 8 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 8 | Completed 5, Terminated 1, Unknown 1, Withdrawn 1 |
| Phase 2 | 1 | Completed 1 |
Follow Hypericum extract LI 160: new trials by email Literature Review of Hypericum extract LI 160 trials Research Report on Hypericum extract LI 160
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pilot Study on Intra-abdominal Photodynamic Diagnosis in Peritoneal Carcinosis St. John's Wort, Photodynamic diagnostic and therapy - Peritoneal Carcinomatosis | Phase 3 | Unknown | University Hospital Tuebingen | 50 | 2017-07-31 | 2017-10-27 |
| St. John's Wort in the Treatment of Raynaud's Phenomenon St. John's Wort, Lactose - Raynaud's Disease | Phase 3 | Completed | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 20 | 2007-03-01 | 2009-07-14 |
| Sertraline Compared With Hypericum Perforatum (St.John's Wort) in Treating Depression Zoloft 50 mg, St. John's Wort 600 mg - Depression, Unspecified Adult Solid Tumor, Protocol Specific | Phase 3 | Completed | Wake Forest University Health Sciences | 2 | 2004-03-01 | 2021-09-09 |
| Homeopathy Assessment in Terms of the Consumption of Analgesics After Knee Ligamentoplasty Arnica montana, 5 CH, Bryonia alba, 5 CH, Hypericum perforatum, 5 CH - Pain | Phase 3 | Terminated | University Hospital, Grenoble | 165 | 2003-12-01 | 2006-11-14 |
| St. John's Wort Extract LI 160 for the Treatment of Atypical Depression St. John's Wort extract, Placebo - Atypical Depression | Phase 3 | Completed | Cassella-med GmbH & Co. KG | 201 | 2002-12-01 | 2009-03-16 |
| St. John's Wort for the Treatment of Generalized Social Anxiety Disorder (GSAD) Hypericum perforatum (St. John's wort) - Anxiety Disorders, Mental Health | Phase 2 / Phase 3 | Completed | National Center for Complementary and Integrative Health (NCCIH) | 56 | 2002-08-01 | 2007-09-26 |
| St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer St. John's wort - Chronic Myeloproliferative Disorders, Fatigue | Phase 3 | Completed | Memorial Sloan Kettering Cancer Center | 1999-12-01 | 2013-01-18 | |
| Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery Hypericum perforatum, docetaxel, placebo - Adult Solid Tumor, Breast Cancer | Phase 3 | Withdrawn | Alliance for Clinical Trials in Oncology | 2016-07-12 |
Anxiety Disorders (1) · Blast Crisis (1) · Breast Neoplasms (1) · Burkitt Lymphoma (1) · Carcinoma, Non-Small-Cell Lung (1) · Depression (1) · Esthesioneuroblastoma, Olfactory (1) · Fatigue (1) · Generalized Anxiety Disorder (1) · Head and Neck Neoplasms (1) · Hodgkin Disease (1) · Immunoblastic Lymphadenopathy (1) · Immunoglobulin Light-chain Amyloidosis (1) · Intraocular Lymphoma (1) · Leukemia (1)
Alliance for Clinical Trials in Oncology (1) · Cassella-med GmbH & Co. KG (1) · London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (1) · Memorial Sloan Kettering Cancer Center (1) · National Center for Complementary and Integrative Health (NCCIH) (1) · University Hospital Tuebingen (1) · University Hospital, Grenoble (1) · Wake Forest University Health Sciences (1)
United States (3) · Canada (1) · France (1) · Germany (1)
Antonius A. Miller, MD (1) · David J. Straus, MD (1) · Edward G. Shaw, MD (1) · Janet E Pope, MD, MPH (1) · Lionel D. Lewis, MD (1) · Stefan Beckert, Prof. Dr. (1) · Wei Zhang, MD (1)
U10CA081851 (1)